HomeInsightsStock Comparison

Indegene Ltd vs Shalby Ltd Stock Comparison

Indegene Ltd vs Shalby Ltd Stock Comparison

Last Updated on: May 28, 2025

Key Highlights

  • The Latest Trading Price of Indegene Ltd is ₹ 606 as of 27 May 15:30.
  • The P/E Ratio of Indegene Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shalby Ltd changed from 18.2 on March 2020 to 30.6 on March 2024 . This represents a CAGR of 10.95% over 5 years.
  • The Market Cap of Indegene Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Shalby Ltd changed from ₹ 500.09 crore on March 2020 to ₹ 2584 crore on March 2024 . This represents a CAGR of 38.89% over 5 years.
  • The revenue of Indegene Ltd for the Mar '25 is ₹ 781.2 crore as compare to the Dec '24 revenue of ₹ 758.1 crore. This represent the growth of 3.05% The revenue of Shalby Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 281.05 crore. This represent the decline of -100%.
  • The ebitda of Indegene Ltd for the Mar '25 is ₹ 173.1 crore as compare to the Dec '24 ebitda of ₹ 169.5 crore. This represent the growth of 2.12% The ebitda of Shalby Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 39.33 crore. This represent the decline of -100%.
  • The net profit of Indegene Ltd changed from ₹ 68.4 crore to ₹ 117.6 crore over 8 quarters. This represents a CAGR of 31.12% The net profit of Shalby Ltd changed from ₹ 20.82 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Indegene Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shalby Ltd changed from 19.31 % on March 2020 to 12.41 % on March 2024 . This represents a CAGR of -8.46% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Indegene Ltd

  • Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
  • Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
  • Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a global provider of solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and healthcare organizations.
  • It provide digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.

About Shalby Ltd

  • Shalby Ltd was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
  • Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
  • Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
  • The Hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Indegene Ltd News Hub

News

Board of Indegene recommends final dividend

Indegene announced that the Board of Directors of the Company at its meeting held on 28 Ap...

Read more

29 Apr 2025 09:26

News

Indegene announces board meeting date

Indegene will hold a meeting of the Board of Directors of the Company on 28 April 2025. Po...

Read more

22 Apr 2025 10:07

News

Indegene launches new center in London

Indegene, a digital-first life sciences commercialization company, today announced the lau...

Read more

19 Mar 2025 19:09

News

Indegene named as winner of Deloitte's Enterprise Growth Awards 2025

Indegene has been recognized as one of the standout winners of Deloitte Private's Enterpri...

Read more

10 Mar 2025 11:11

News

Indegene named as winner of Deloitte's Enterprise Growth Awards 2025

Indegene has been recognized as one of the standout winners of Deloitte Private's Enterpri...

Read more

10 Mar 2025 11:11

News

Indegene launches Gen-AI platform - Cortex

Indegene launched Cortex, a fit-for-purpose Generative AI (GenAI) platform, verticalized f...

Read more

24 Feb 2025 15:44

Shalby Ltd News Hub

News

Shalby to conduct board meeting

Shalby will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powere...

Read more

21 May 2025 18:40

News

Shalby slides after reporting net loss of Rs 2 cr in Q3

However, revenue from operations jumped 27.6% YoY to Rs 275.63 crore in the quarter ended ...

Read more

04 Feb 2025 12:11

News

Shalby to convene board meeting

Shalby will hold a meeting of the Board of Directors of the Company on 3 February 2025. Po...

Read more

28 Jan 2025 15:22

News

Shalby gains on USFDA clearance for knee replacement device

Duraniom is the company's primary total knee replacement device with TiNbN coating. Based ...

Read more

16 Jan 2025 11:13

News

Shalby slides after Q2 PAT tumbles 88% YoY to Rs 3 cr

Profit before tax (PBT) stood at Rs 13.70 crore in Q2 FY25, up 67.86% YoY and down 54.95% ...

Read more

30 Oct 2024 17:14

News

Shalby to table results

Shalby will hold a meeting of the Board of Directors of the Company on 30 October 2024. Po...

Read more

23 Oct 2024 16:19

SWOT Analysis Of Indegene Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Shalby Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indegene Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Shalby Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Indegene Ltd and Shalby Ltd

Which company has a larger market capitalization, Indegene Ltd or Shalby Ltd?

Market cap of Indegene Ltd is 14,547 Cr while Market cap of Shalby Ltd is 2,157 Cr

What are the key factors driving the stock performance of Indegene Ltd and Shalby Ltd?

The stock performance of Indegene Ltd and Shalby Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indegene Ltd and Shalby Ltd?

As of May 28, 2025, the Indegene Ltd stock price is INR ₹606.0. On the other hand, Shalby Ltd stock price is INR ₹199.75.

How do dividend payouts of Indegene Ltd and Shalby Ltd compare?

To compare the dividend payouts of Indegene Ltd and Shalby Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions